Chris Markoch

Chris Markoch

About Chris Markoch

Chris Markoch is a freelance financial writer who is passionate in finding the story behind the stock. A stock chart and fundamental analysis can show and tell investors what is happening. But for long-term investing success, the question that has to be answered is “Why”?

To help answer that question, Chris brings a marketing background to his research and writing. Writers by nature are curious so Chris will often look at a stock’s performance and like any marketer ask, “So what?” Good stocks don’t suddenly become bad. Bad stocks don’t suddenly become good.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com.

Recent Articles

ChargePoint Stock Has a Really Compelling Long Term Case

The bullish case for CHPT stock comes down to whether you believe the charging infrastructure has to lead the way to our nation's EV future.

FuboTV Stock May Be a Short Squeeze Play, But It’s Also a Good Bet

FUBOTV is part of the meme stock trade, but I believe that patient investors will find that FUBO stock is strong enough to stand on its own.

Can General Electric Win Over Skeptics in Earnings Season?

GE stock is rangebound and analyst sentiment is neutral to bearish. A positive earnings report may help make a bullish case clearer.  

Up Against Ethereum, Is Tezos a Strong Contender or Overhyped Pretender?

XTZ, like many altcoins, appears to bear similarities with Ethereum. The question becomes whether Tezos can make itself different. 

Novavax Will Be Volatile Until the Company Delivers Answers

NVAX stock has been making some volatile moves in 2021. And that volatility will continue until its Covid-19 vaccine gets regulatory approval.